Molecules and Cells

Cited by CrossRef (9)

  1. Tianyu He, Ziheng Wu, Pinghui Xia, Weidong Wang, Hua Sun, Li Yu, Wang Lv, Jian Hu. The combination of a seven-autoantibody panel with computed tomography scanning can enhance the diagnostic efficiency of non-small cell lung cancer. Front. Oncol. 2022;12
    https://doi.org/10.3389/fonc.2022.1047019
  2. Yoojung Kwon, Misun Kim, Hyun Suk Jung, Youngmi Kim, Dooil Jeoung. Targeting Autophagy for Overcoming Resistance to Anti-EGFR Treatments. Cancers 2019;11:1374
    https://doi.org/10.3390/cancers11091374
  3. Manvendra Kumar, Gaurav Joshi, Joydeep Chatterjee, Raj Kumar. Epidermal Growth Factor Receptor and its Trafficking Regulation by Acetylation: Implication in Resistance and Exploring the Newer Therapeutic Avenues in Cancer. CTMC 2020;20:1105
    https://doi.org/10.2174/1568026620666200207100227
  4. Tong Lou, Chongdong Liu, Hong Qu, Zhiqiang Zhang, Shuzhen Wang, Huiyu Zhuang. FOXA1 can be modulated by HDAC3 in the progression of epithelial ovarian carcinoma. J Transl Med 2022;20
    https://doi.org/10.1186/s12967-021-03224-3
  5. Minjeong Yeon, Jaewhan Byun, Hyuna Kim, Misun Kim, Hyun Suk Jung, Doyong Jeon, Youngmi Kim, Dooil Jeoung. CAGE Binds to Beclin1, Regulates Autophagic Flux and CAGE-Derived Peptide Confers Sensitivity to Anti-cancer Drugs in Non-small Cell Lung Cancer Cells. Front. Oncol. 2018;8
    https://doi.org/10.3389/fonc.2018.00599
  6. Leilei He, Lixia Gao, Chloe Shay, Liwei Lang, Fenglin Lv, Yong Teng. Histone deacetylase inhibitors suppress aggressiveness of head and neck squamous cell carcinoma via histone acetylation-independent blockade of the EGFR-Arf1 axis. J Exp Clin Cancer Res 2019;38
    https://doi.org/10.1186/s13046-019-1080-8
  7. Yoojung Kwon, Youngmi Kim, Hyun Jung, Dooil Jeoung. Role of HDAC3-miRNA-CAGE Network in Anti-Cancer Drug-Resistance. IJMS 2018;20:51
    https://doi.org/10.3390/ijms20010051
  8. Minjeong Yeon, Seungheon Lee, Joo-Eun Lee, Hyun Suk Jung, Youngmi Kim, Dooil Jeoung. CAGE-miR-140-5p-Wnt1 Axis Regulates Autophagic Flux, Tumorigenic Potential of Mouse Colon Cancer Cells and Cellular Interactions Mediated by Exosomes. Front. Oncol. 2019;9
    https://doi.org/10.3389/fonc.2019.01240
  9. Hyein Jo, Kyeonghee Shim, Dooil Jeoung. Potential of the miR-200 Family as a Target for Developing Anti-Cancer Therapeutics. IJMS 2022;23:5881
    https://doi.org/10.3390/ijms23115881